FDA approves first-of-a-kind seasonal flu vaccine
November 22, 2012 (WASHINGTON) -- The Food and Drug Administration says it has approved the first seasonal flu vaccine made using animal cell technology, rather than the half-century egg method.
The FDA approved Novartis' Flucelvax to prevent influenza in people 18 years and older.
The new method has been promoted by U.S. health officials because it is faster than egg-based production and could speed up manufacturing in the event of a pandemic.
In the older method, virus samples are injected into specialized chicken eggs and incubated. The egg fluids are later harvested, concentrated and purified into the vaccine.
With cell technology, small amounts of virus are put in fermenting tanks with nutrients and cells derived from mammals. The virus is then inactivated, purified and put into vaccine vials.
- Beverly mom, children found safe in Wisconsin 24 min ago
- Photos released in Yellow Line attack
- Lake Station mayor, family plead not guilty to corruption charges
- ABC7 First Alert Weather Forecast
- Program Note: Jeopardy to air Late Night
- Truck driver released after boy dies in Ind. hit-and-run
- Obama: 8 million signed up for health care 23 min ago
- Boy, 15, charged as adult in South Side shooting
- Waukegan couple's spat yields 16-officer response, 2 hurt
- Chelsea Clinton expecting 1st child
- US decries anti-Semitic leaflets in Ukraine
- Blackhawks set for playoffs Thursday with STL Blues Game 1 19 min ago
- Chicago Bulls launch 'SEE RED' playoff campaign 19 min ago
- abcnews: Ferry Captain Among 1st to Abandon Ship 31 min ago
- Fans gear up for Bulls, Blackhawks playoffs
20 min ago
Most Viewed StoriesMost Viewed Photos